Evgeny N Imyanitov


Ontology type: schema:Person     


Person Info

NAME

Evgeny N

SURNAME

Imyanitov

Publications in SciGraph latest 50 shown

  • 2019-12 Shared heritability and functional enrichment across six solid cancers in NATURE COMMUNICATIONS
  • 2018-06 First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients in CLINICAL DRUG INVESTIGATION
  • 2018-05 Multigene sequencing reveals heterogeneity of NLRP12-related autoinflammatory disorders in RHEUMATOLOGY INTERNATIONAL
  • 2018-05 Pattern of TSC1 and TSC2 germline mutations in Russian patients with tuberous sclerosis in JOURNAL OF HUMAN GENETICS
  • 2017-12 Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer in NATURE GENETICS
  • 2017-10 Highly Sensitive and Reliable Detection of EGFR Exon 19 Deletions by Droplet Digital Polymerase Chain Reaction in MOLECULAR DIAGNOSIS & THERAPY
  • 2017-10 Detection of BRCA1 gross rearrangements by droplet digital PCR in BREAST CANCER RESEARCH AND TREATMENT
  • 2017-05 Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer in NATURE GENETICS
  • 2017-01 Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3 in BREAST CANCER RESEARCH AND TREATMENT
  • 2016-12 Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women in BREAST CANCER RESEARCH
  • 2016-12 Complete Clinical Response of BRAF-Mutated Cholangiocarcinoma to Vemurafenib, Panitumumab, and Irinotecan in JOURNAL OF GASTROINTESTINAL CANCER
  • 2016-12 Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 in BREAST CANCER RESEARCH
  • 2016-12 Cytotoxic and targeted therapy for hereditary cancers in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2016-12 Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus in BREAST CANCER RESEARCH
  • 2016-09-07 Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus in NATURE COMMUNICATIONS
  • 2016-09 BRCA1-deficient breast cancer cell lines are resistant to MEK inhibitors and show distinct sensitivities to 6-thioguanine in SCIENTIFIC REPORTS
  • 2016-08 Distribution of EGFR Mutations in 10,607 Russian Patients with Lung Cancer in MOLECULAR DIAGNOSIS & THERAPY
  • 2016-05 Evidence for a pathogenic role of BRCA1 L1705P and W1837X germ-line mutations in MOLECULAR BIOLOGY REPORTS
  • 2016-04-27 Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer in NATURE COMMUNICATIONS
  • 2016-04 Vemurafenib-induced progression of breast cancer: a case report and review of the literature in TARGETED ONCOLOGY
  • 2016-04 Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 in NATURE GENETICS
  • 2015-12 An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers in BREAST CANCER RESEARCH
  • 2015-10 BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment in INVESTIGATIONAL NEW DRUGS
  • 2015-04 High efficacy of cisplatin neoadjuvant therapy in a prospective series of patients carrying BRCA1 germ-line mutation in MEDICAL ONCOLOGY
  • 2015-03 Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe in FAMILIAL CANCER
  • 2015-02 Identification of six new susceptibility loci for invasive epithelial ovarian cancer in NATURE GENETICS
  • 2014-12 Breast cancer sensitivity to neoadjuvant therapy in BRCA1 and CHEK2 mutation carriers and non-carriers in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-12 Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers in BREAST CANCER RESEARCH
  • 2014-12 The frequency of the BLM*p.Q548X (c.1642C > T) mutation in breast cancer patients from Russia in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-10 Evidence for clinical efficacy of mitomycin C in heavily pretreated ovarian cancer patients carrying germ-line BRCA1 mutation in MEDICAL ONCOLOGY
  • 2014-06 Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-02 Development of breast tumors in CHEK2, NBN/NBS1 and BLM mutation carriers does not commonly involve somatic inactivation of the wild-type allele in MEDICAL ONCOLOGY
  • 2013-12 Systemic treatment for hereditary cancers: a 2012 update in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2013-09 Evidence for angiogenesis-independent contribution of VEGFR1 (FLT1) in gastric cancer recurrence in MEDICAL ONCOLOGY
  • 2013-09 Pattern of clinically relevant mutations in consecutive series of Russian colorectal cancer patients in MEDICAL ONCOLOGY
  • 2013-06 Evidence for predictive role of BRCA1 and bTUBIII in gastric cancer in MEDICAL ONCOLOGY
  • 2013-04 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer in NATURE GENETICS
  • 2013-03 Value of bilateral breast cancer for identification of rare recessive at-risk alleles: evidence for the role of homozygous GEN1 c.2515_2519delAAGTT mutation in FAMILIAL CANCER
  • 2013 Ovarian Cancer Genome in OVARIAN CANCER
  • 2012-12 Systemic therapy for hereditary cancer in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2012-11 Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers in BREAST CANCER RESEARCH AND TREATMENT
  • 2012-10 Age-related and clinicopathological features of colorectal cancer associated with K-ras gene status in ADVANCES IN GERONTOLOGY
  • 2012-03 Endocrine Metabolic Disorders in Patients with Breast Cancer, Carriers of BRCA1 Gene Mutations in BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
  • 2012-02 High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas in BREAST CANCER RESEARCH AND TREATMENT
  • 2012-02 Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers in BREAST CANCER RESEARCH
  • 2011-12 Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 in BREAST CANCER RESEARCH
  • 2011-12 Drug therapy for hereditary cancers in HEREDITARY CANCER IN CLINICAL PRACTICE
  • 2011-04 Exploring the link between MORF4L1 and risk of breast cancer in BREAST CANCER RESEARCH
  • 2011-04 PALB2 mutations in German and Russian patients with bilateral breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2011-04 Mixed epithelial/mesenchymal metaplastic carcinoma (carcinosarcoma) of the breast in BRCA1 carrier in BREAST CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.465337.0", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.445931.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.1049.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415628.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.10423.34", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.15447.33", 
            "type": "Organization"
          }
        ], 
        "familyName": "Imyanitov", 
        "givenName": "Evgeny N", 
        "id": "sg:person.01154107266.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154107266.93"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:57", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_667.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01154107266.93'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01154107266.93'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01154107266.93'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01154107266.93'


     

    This table displays all metadata directly associated to this object as RDF triples.

    26 TRIPLES      10 PREDICATES      16 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01154107266.93 schema:affiliation N5cdbe93e9a2844ec9580700e1b600851
    2 https://www.grid.ac/institutes/grid.10423.34
    3 https://www.grid.ac/institutes/grid.1049.c
    4 https://www.grid.ac/institutes/grid.15447.33
    5 https://www.grid.ac/institutes/grid.415628.c
    6 https://www.grid.ac/institutes/grid.445931.e
    7 schema:familyName Imyanitov
    8 schema:givenName Evgeny N
    9 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154107266.93
    10 schema:sdDatePublished 2019-03-07T14:57
    11 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    12 schema:sdPublisher Nf23faee4a54045bc96ad4fdb74f6a5e6
    13 sgo:license sg:explorer/license/
    14 sgo:sdDataset persons
    15 rdf:type schema:Person
    16 N5cdbe93e9a2844ec9580700e1b600851 schema:affiliation https://www.grid.ac/institutes/grid.465337.0
    17 sgo:isCurrent true
    18 rdf:type schema:OrganizationRole
    19 Nf23faee4a54045bc96ad4fdb74f6a5e6 schema:name Springer Nature - SN SciGraph project
    20 rdf:type schema:Organization
    21 https://www.grid.ac/institutes/grid.10423.34 schema:Organization
    22 https://www.grid.ac/institutes/grid.1049.c schema:Organization
    23 https://www.grid.ac/institutes/grid.15447.33 schema:Organization
    24 https://www.grid.ac/institutes/grid.415628.c schema:Organization
    25 https://www.grid.ac/institutes/grid.445931.e schema:Organization
    26 https://www.grid.ac/institutes/grid.465337.0 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...